Oral administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis.
about
Therapeutic neuroprotective agents for amyotrophic lateral sclerosisEffects of prolonged treatment with memantine in the MRL model of CNS lupus.One universal common endpoint in mouse models of amyotrophic lateral sclerosis.Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS miceCharacterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis.Gacyclidine improves the survival and reduces motor deficits in a mouse model of amyotrophic lateral sclerosis.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Potential new complication in drug therapy development for amyotrophic lateral sclerosis.Current and emerging treatments for amyotrophic lateral sclerosis.A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis.Suppression of CHRN endocytosis by carbonic anhydrase CAR3 in the pathogenesis of myasthenia gravis.Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.Excitatory Dendritic Mitochondrial Calcium Toxicity: Implications for Parkinson's and Other Neurodegenerative Diseases
P2860
Q27015029-A6601238-AD05-4534-9E8C-E0B0147E63C8Q30612050-22835040-D854-4320-BDA6-2D640E3944ECQ33936763-1CA721E1-C861-4D08-A125-A46E4877AA42Q35058671-01BFA848-6F19-4DE9-990A-F4AE911F50AEQ36299228-E6A6ABCE-43D4-4AEC-9A96-F8731ABCC3ECQ37415516-3FA6B25E-ED07-43AD-B81D-86931F32A2B1Q38573829-F1DBA206-7A8F-459A-A090-ECC0CA51C87FQ38847200-A52D81A1-959A-4484-85D7-1FA18663FB6DQ38881707-123C96B8-4444-4CDE-9E52-5AA2AF70DE87Q42685032-B7E439DD-BEC0-49AE-856F-D83C0449E9B3Q43011186-31E19B0A-8E6F-4E9F-BCFF-40F9DEA8E40DQ47768895-A8D2BAC9-881F-413B-BBAA-0FD103454C27Q49905442-22F60D99-EB3B-480A-B572-E18EBBA40B86Q50904589-48E37FCA-173D-4973-96F4-C2528B3578A8Q58803405-E26B090F-0403-4F0B-991D-67C96B2AD04B
P2860
Oral administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oral administration of memanti ...... amyotrophic lateral sclerosis.
@en
Oral administration of memanti ...... amyotrophic lateral sclerosis.
@nl
type
label
Oral administration of memanti ...... amyotrophic lateral sclerosis.
@en
Oral administration of memanti ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Oral administration of memanti ...... amyotrophic lateral sclerosis.
@en
Oral administration of memanti ...... amyotrophic lateral sclerosis.
@nl
P2093
P2860
P356
P1476
Oral administration of memanti ...... amyotrophic lateral sclerosis.
@en
P2093
Dong-Hoon Hwang
In-Soo Joo
Jung-Im Seok
Sang-Kun Shin
Seung-Up Kim
P2860
P304
P356
10.3988/JCN.2007.3.4.181
P577
2007-12-20T00:00:00Z